Invention Grant
- Patent Title: Pharmaceutical composition comprising guttiferone F for the treatment of prostate cancer
- Patent Title (中): 包含用于治疗前列腺癌的葡聚糖F的药物组合物
-
Application No.: US14333524Application Date: 2014-07-17
-
Publication No.: US09408811B2Publication Date: 2016-08-09
- Inventor: Hongxi Xu , Xin Li , Hong Zhang , Yuanzhi Lao , Hongsheng Tan , Xiaoyu Wang , Kaixian Chen , Zhaoxiang Bian , Dajian Yang , Shilin Chen , Aiping Lu , Albert Sun Chi Chan
- Applicant: Hong Kong Baptist University
- Applicant Address: HK Hong Kong
- Assignee: Hong Kong Baptist University
- Current Assignee: Hong Kong Baptist University
- Current Assignee Address: HK Hong Kong
- Agency: Ella Cheong Hong Kong
- Agent Sam T. Yip
- Main IPC: C07C33/38
- IPC: C07C33/38 ; C07C35/23 ; A61K31/122 ; A61K36/38

Abstract:
Prostate cancer is the most commonly diagnosed cancer in males and one of the leading causes of cancer death. Although treatment options have increased for some patients, overall progress has been modest. Thus, there is a great need to develop new treatments. This invention relates to a method for treating cancer comprising using an anti-cancer compound of formula (I): More particularly, it relates to said anti-prostate cancer compound that can be isolated from Garcinia esculenta or chemically synthesized and its specific anticancer/antitumor activity. The invention has a specific application in treating human prostate cancer.
Public/Granted literature
- US20150025155A1 ANTI-PROSTATE CANCER COMPOUND AND METHOD OF USE THEREOF Public/Granted day:2015-01-22
Information query